Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate passes Right‑to‑Try bill allowing terminal patients access to investigational treatments
Summary
The Senate passed a fifth substitute of House Bill 94, a Right‑to‑Try measure enabling terminally ill patients to access investigational drugs and devices after phase I trials, with safeguards for patients, providers, insurers and manufacturers. The bill passed second reading and was placed on the third‑reading calendar.
Senate members advanced House Bill 94 (fifth substitute), commonly called the Right‑to‑Try bill, after floor debate emphasizing patient access and multiple protections for stakeholders.
Sponsor Senator Vickers described the measure as granting terminally ill patients who have exhausted conventional options access to drugs or devices that have successfully completed phase…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
